Johnson & Johnson cited Motrin and Tylenol as ‘major contributors to growth’ in its over-the-counter division
Read Full Story
Latest posts by Market Watch (see all)
- Key Words: California reparations push needs to be a ‘game-changer,’ author of bill says - January 27, 2023
- Earnings Outlook: AMD earnings face even more scrutiny after ‘astonishingly bad’ Intel outlook - January 27, 2023
- : S&P downgrades Bed Bath & Beyond, says beleaguered retailer has ‘insufficient funds’ to repay its financial obligations - January 27, 2023
